Manufacturer Channel Strategy Highlights SPT Week in Review

5. Real-World Data Shows Benefit of Multiple Sclerosis Drug

Fingolimod (Gilenya) reduced disease progression in patients with relapsing-remitting multiple sclerosis.

https://www.specialtypharmacytimes.com/news/real-world-data-shows-benefit-of-multiple-sclerosis-drug

4. New Cholesterol Drug Shows Superiority to Pravastatin in HIV Patients

Pitavastatin lowered LDL cholesterol levels in patients with HIV and dyslipidemia.

https://www.specialtypharmacytimes.com/news/new-cholesterol-drug-shows-superiority-to-pravastatin-in-hiv-patients

3. Specialty Pharmacy Accreditation More Important Than Ever

Specialty pharmacy is the fastest growing segment thanks to drug innovation that is driving health care costs.

https://www.specialtypharmacytimes.com/news/specialty-pharmacy-accreditation-more-important-than-ever

2. Challenges for Value-Based Contracting in Specialty Pharmacy

The transition to value-based reimbursement is likely to shape the future of health care.

https://www.specialtypharmacytimes.com/news/challenges-for-value-based-contracting-in-specialty-pharmacy

1. Manufacturer Channel Strategy for Specialty Drugs

Exclusive, limited, and open networks each have pros and cons that must be weighed heavily.

https://www.specialtypharmacytimes.com/news/manufacturer-channel-strategy-for-specialty-drugs